Anti-CHSTA/ CHST10/ HNK-1ST functional antibody

Anti-CHSTA/ CHST10/ HNK-1ST functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CHST10/CHST10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0082-Ab-1/ GM-Tg-hg-SE0082-Ab-2Anti-Human CHST10 monoclonal antibodyHuman
GM-Tg-rg-SE0082-Ab-1/ GM-Tg-rg-SE0082-Ab-2Anti-Rat CHST10 monoclonal antibodyRat
GM-Tg-mg-SE0082-Ab-1/ GM-Tg-mg-SE0082-Ab-2Anti-Mouse CHST10 monoclonal antibodyMouse
GM-Tg-cynog-SE0082-Ab-1/ GM-Tg-cynog-SE0082-Ab-2Anti-Cynomolgus/ Rhesus macaque CHST10 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0082-Ab-1/ GM-Tg-felg-SE0082-Ab-2Anti-Feline CHST10 monoclonal antibodyFeline
GM-Tg-cang-SE0082-Ab-1/ GM-Tg-cang-SE0082-Ab-2Anti-Canine CHST10 monoclonal antibodyCanine
GM-Tg-bovg-SE0082-Ab-1/ GM-Tg-bovg-SE0082-Ab-2Anti-Bovine CHST10 monoclonal antibodyBovine
GM-Tg-equg-SE0082-Ab-1/ GM-Tg-equg-SE0082-Ab-2Anti-Equine CHST10 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0082-Ab-1/ GM-Tg-hg-SE0082-Ab-2; GM-Tg-rg-SE0082-Ab-1/ GM-Tg-rg-SE0082-Ab-2;
GM-Tg-mg-SE0082-Ab-1/ GM-Tg-mg-SE0082-Ab-2; GM-Tg-cynog-SE0082-Ab-1/ GM-Tg-cynog-SE0082-Ab-2;
GM-Tg-felg-SE0082-Ab-1/ GM-Tg-felg-SE0082-Ab-2; GM-Tg-cang-SE0082-Ab-1/ GM-Tg-cang-SE0082-Ab-2;
GM-Tg-bovg-SE0082-Ab-1/ GM-Tg-bovg-SE0082-Ab-2; GM-Tg-equg-SE0082-Ab-1/ GM-Tg-equg-SE0082-Ab-2
Products NameAnti-CHST10 monoclonal antibody
Formatmab
Target NameCHST10
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CHST10 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0082-Ag-1Recombinant multi-species CHSTA/ CHST10/ HNK-1ST protein
    ORF Viral VectorpGMLPm003983mouse Chst10 Lentivirus plasmid
    ORF Viral VectorvGMLPm003983mouse Chst10 Lentivirus particle


    Target information

    Target IDGM-SE0082
    Target NameCHST10
    Gene ID9486,98388,140568,709939,474555,101082996,511215,100050281
    Gene Symbol and SynonymsCHST10,HNK-1ST,HNK1ST,ST
    Uniprot AccessionO43529,O54702
    Uniprot Entry NameCHSTA_HUMAN,CHSTA_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000115526
    Target ClassificationN/A

    The target: CHST10, gene name: CHST10, also named as HNK-1ST, HNK1ST. This protein encoded by this gene transfers sulfate to the C-3 hydroxyl of terminal glucuronic acid of protein- and lipid-linked oligosaccharides. This protein was first identified as a sulfotransferase that acts on the human natural killer-1 (HNK-1) glycan; HNK-1 is a carbohydrate involved in neurodevelopment and synaptic plasticity.[provided by RefSeq, Feb 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.